Vashishta A, Fusek M, Vetvicka V
Department of Pathology and Laboratory Medicine, School of Medicine, University of Louisville, Louisville, KY 40292, USA.
Folia Microbiol (Praha). 2005;50(1):71-6. doi: 10.1007/BF02931296.
For the past ten years, our research has been focused on elucidating the mechanism by which procathepsin D (pCD) impacts cancer development. Various studies have shown that pCD is overexpressed and secreted by numerous cancer cell lines. After secretion, it exhibits "growth hormone-like" activity on cancerous cells but the exact mechanism of this mitogenic activity is not yet understood. The activation peptide of pCD (APpCD) (which is cleaved off upon activation of the zymogen) is responsible for the mitogenic function of pCD. Various in vitro and in vivo studies support our theory that the APpCD interacts with both parent and neighborhood cancer cells and thus functions as an autocrine mitogen. We propose a model of pCD mitogenic function and also some possible approaches for treatment and prevention of certain types of cancer.
在过去十年中,我们的研究一直专注于阐明组织蛋白酶D前体(pCD)影响癌症发展的机制。各种研究表明,pCD在众多癌细胞系中过表达并分泌。分泌后,它对癌细胞表现出“生长激素样”活性,但这种促有丝分裂活性的确切机制尚不清楚。pCD的激活肽(APpCD)(在酶原激活时被切割掉)负责pCD的促有丝分裂功能。各种体外和体内研究支持我们的理论,即APpCD与亲代癌细胞和邻近癌细胞相互作用,从而作为一种自分泌促有丝分裂原发挥作用。我们提出了一个pCD促有丝分裂功能的模型,以及一些治疗和预防某些类型癌症的可能方法。